| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |